TIDMGSK
RNS Number : 6938X
GlaxoSmithKline PLC
05 May 2021
GlaxoSmithKline plc
Results of Annual General Meeting
GlaxoSmithKline plc ('GSK') held its Annual General Meeting
('AGM') at 2.30pm on Wednesday 5 May 2021.
The statement made by the Chairman at the AGM will shortly be
available to view on GSK's website at www.gsk.com .
All valid proxy votes (whether submitted electronically or in
hard copy form) were included in the poll taken at the meeting.
The table below shows the results of the poll on all 22
resolutions. The full text of the resolutions is contained in the
Notice of AGM published on 30 March 2021, which is available on
GSK's website at www.gsk.com .
Resolution Total votes % Total % Total votes Votes
for (1)(2) votes against cast withheld
(2) (3)
Receive and adopt
the 2020 Annual
1 Report 3,475,135,362 98.81 41,757,734 1.19 3,516,893,096 11,603,440
------------------------ -------------- ------ --------------- ----- -------------- -----------
Approve the Annual
2 report on remuneration 3,272,132,033 93.14 240,932,159 6.86 3,513,064,192 15,444,148
------------------------ -------------- ------ --------------- ----- -------------- -----------
Re-election of
3 Sir Jonathan Symonds 3,499,343,831 99.52 16,763,629 0.48 3,516,107,460 12,371,547
------------------------ -------------- ------ --------------- ----- -------------- -----------
Re-election of
4 Dame Emma Walmsley 3,507,017,955 99.68 11,159,384 0.32 3,518,177,339 10,359,075
------------------------ -------------- ------ --------------- ----- -------------- -----------
Re-election of
5 Charles Bancroft 3,506,975,009 99.74 9,026,131 0.26 3,516,001,140 12,472,435
------------------------ -------------- ------ --------------- ----- -------------- -----------
Re-election of
6 Vindi Banga 3,496,064,409 99.43 19,904,292 0.57 3,515,968,701 12,509,463
------------------------ -------------- ------ --------------- ----- -------------- -----------
Re-election of
7 Dr Hal Barron 3,507,018,967 99.69 10,733,599 0.31 3,517,752,566 10,738,305
------------------------ -------------- ------ --------------- ----- -------------- -----------
Re-election of
8 Dr Vivienne Cox 3,497,451,811 99.46 18,813,391 0.54 3,516,265,202 12,207,081
------------------------ -------------- ------ --------------- ----- -------------- -----------
Re-election of
9 Lynn Elsenhans 3,434,728,312 97.69 81,301,678 2.31 3,516,029,990 12,440,783
------------------------ -------------- ------ --------------- ----- -------------- -----------
Re-election of
10 Dr Laurie Glimcher 3,508,174,526 99.77 7,947,259 0.23 3,516,121,785 12,353,907
------------------------ -------------- ------ --------------- ----- -------------- -----------
Re-election of
11 Dr Jesse Goodman 3,506,872,640 99.74 9,131,605 0.26 3,516,004,245 12,467,159
------------------------ -------------- ------ --------------- ----- -------------- -----------
Re-election of
12 Iain Mackay 3,501,889,913 99.56 15,637,087 0.44 3,517,527,000 10,951,129
------------------------ -------------- ------ --------------- ----- -------------- -----------
Re-election of
13 Urs Rohner 3,484,061,208 99.10 31,702,634 0.90 3,515,763,842 12,752,529
------------------------ -------------- ------ --------------- ----- -------------- -----------
Re-appointment
14 of the auditor 3,512,936,007 99.84 5,521,996 0.16 3,518,458,003 10,024,350
------------------------ -------------- ------ --------------- ----- -------------- -----------
Remuneration of
15 the auditor 3,511,280,034 99.82 6,176,678 0.18 3,517,456,712 11,022,183
------------------------ -------------- ------ --------------- ----- -------------- -----------
Authority for the
company to make
donations to political
organisations and
incur political
16 expenditure 3,440,815,513 98.36 57,276,887 1.64 3,498,092,400 30,393,327
------------------------ -------------- ------ --------------- ----- -------------- -----------
Authority to allot
17 shares 3,362,807,250 95.66 152,632,653 4.34 3,515,439,903 13,038,799
------------------------ -------------- ------ --------------- ----- -------------- -----------
Disapplication
of pre-emption
rights - general
18 power (4) 3,368,593,428 95.88 144,660,127 4.12 3,513,253,555 15,222,364
------------------------ -------------- ------ --------------- ----- -------------- -----------
Disapplication
of pre-emption
rights - in connection
with an acquisition
or specified capital
19 investment (4) 3,291,504,396 93.68 221,978,886 6.32 3,513,483,282 14,999,454
------------------------ -------------- ------ --------------- ----- -------------- -----------
Authority for the
company to purchase
its own shares
20 (4) 3,449,168,275 98.36 57,436,714 1.64 3,506,604,989 21,875,135
------------------------ -------------- ------ --------------- ----- -------------- -----------
Exemption from
statement of senior
statutory auditor's
21 name 3,477,878,016 99.47 18,543,893 0.53 3,496,421,909 31,294,363
------------------------ -------------- ------ --------------- ----- -------------- -----------
Authority for reduced
notice of a general
meeting other than
22 an AGM (4) 3,286,542,818 93.50 228,494,172 6.50 3,515,036,990 12,675,849
------------------------ -------------- ------ --------------- ----- -------------- -----------
Notes:
(1) The "for" votes include those giving the Chairman discretion. In
line with the notification issued to American Depositary Receipt
(ADR) holders last year, GSK did not instruct its ADR Depositary
to vote any unvoted ADRs in respect of the AGM resolutions.
(2) Votes "for" and "against" are expressed as a percentage of the
total votes cast.
(3) A vote withheld is not a vote in law and is not counted in the
calculation of the proportion of votes "for" or "against" a resolution.
(4) Indicates Special Resolutions requiring a 75% majority.
The following table provides further relevant information:
GSK's GSK's
Twenty first Twentieth
AGM AGM
(2021) (2020)
Issued share capital (excluding Treasury
Shares) 5,031,444,276 5,017,091,542
--------------- --------------
Total votes cast and votes withheld
lodged as a % of GSK's issued share
capital (excluding Treasury Shares) 70.11% 72.60%
--------------- --------------
Total shareholder population 100,906 105,353
--------------- --------------
Total number of proxies lodged 6,089 6,268
--------------- --------------
% of shareholders who lodged proxies 6.03% 5.95%
--------------- --------------
The above poll results will shortly be available on the
company's website at www.gsk.com . In accordance with Listing Rule
9.6.2, a copy of the resolutions, other than those concerning
ordinary business, will be submitted to the UK Listing Authority
and will in due course be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
V A Whyte
Company Secretary
5 May 2021
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGDKPBBOBKDDPK
(END) Dow Jones Newswires
May 05, 2021 13:23 ET (17:23 GMT)
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024
